AS

Anshu Sahay

Director DIN 07209466
DIN 07209466 First appointment Sep 2015
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Anshu Sahay

Data last updated:

Anshu Sahay was an Additional Director at Mediport Healthtech Private Limited (from 2015) and Director at Nerve24 Technologies Private Limited (from 2016).

DIN 07209466
First Appointment 05 Sep 2015
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mediport Healthtech Private Limited U74120MH2015PTC267870
Additional Director05 Sep 20152015Strike Off
Nerve24 Technologies Private Limited U74999MH2016PTC282347
Director14 Jun 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mediport Healthtech Private Limited
Nerve24 Technologies Private Limited
Premium access

Shareholding and investment profile for Anshu Sahay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anshu Sahay

Anshu Sahay was first appointed on 05 Sep 2015 as Additional Director at Mediport Healthtech Private Limited. The most recent appointment on record is 14 Jun 2016 at Nerve24 Technologies Private Limited.

Anshu Sahay held 2 earlier board appointments: Mediport Healthtech Private Limited (Additional Director, from 05 Sep 2015); Nerve24 Technologies Private Limited (Director, from 14 Jun 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available